Drugs & Therapy Perspectives

, Volume 28, Issue 9, pp 1–4

Ulipristal acetate: a guide to its use in uterine fibroids

  • Katherine A. Lyseng-Williamson
  • Jamie D. Croxtall
Adis Drug Clinical Q&A


Oral ulipristal acetate (Esmya™), a selective progesterone-receptor modulator, is an effective and well tolerated option for the pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. It is associated with rapid control of excessive uterine bleeding and sustained reductions in uterine fibroid volume.


  1. 1.
    Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Myomas and reproductive function. Fertil Steril 2008; 90 (5 Suppl.): S125–30CrossRefGoogle Scholar
  2. 2.
    McCarthy-Keith DM, Armstrong AY. Innovations in uterine fibroid therapy. Therapy 2011; 8 (2): 189–200CrossRefGoogle Scholar
  3. 3.
    Duhan N. Current and emerging treatments for uterine myoma: an update. Int J Womens Health 2011; 3 (1): 231–42PubMedCrossRefGoogle Scholar
  4. 4.
    Stewart EA. Uterine fibroids and evidence-based medicine: not an oxymoron. N Engl J Med 2012 Feb 2; 366 (5): 471–3PubMedCrossRefGoogle Scholar
  5. 5.
    Esmya 5 mg tablets (ulipristal acetate): summary of product characteristics. London: European Medicines Agency, 2012 Mar 15Google Scholar
  6. 6.
    Croxtall JD. Ulipristal acetate in uterine fibroids. Drugs 2012; 72 (8): 1075–85PubMedCrossRefGoogle Scholar
  7. 7.
    Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2007 Sep; 92 (9): 3582–9PubMedCrossRefGoogle Scholar
  8. 8.
    Yoshida S, Ohara N, Xu Q, et al. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med 2010 May; 28 (3): 260–73PubMedCrossRefGoogle Scholar
  9. 9.
    Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012 Feb 2; 366 (5): 409–20PubMedCrossRefGoogle Scholar
  10. 10.
    Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012 Feb 2; 366 (5): 421–32PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  • Katherine A. Lyseng-Williamson
    • 1
  • Jamie D. Croxtall
    • 1
  1. 1.AdisAucklandNew Zealand

Personalised recommendations